At the current price of $3, what are market expectations regarding Cellectis SA’s future operating performance? To achieve average annual stock market performance of 9.0% over the next 6 years, Cellectis SA shares will need to reach $5. To achieve Upper quartile performance, Cellectis SA’s stock price will need to reach $6 by 2028.
Executive Summary
- Price Target Research identifies Cellectis SA as having: above average expected growth, low financial strength, low profitability, and low stability.
- Average valuation, leading shareholder returns. Current valuation levels are average relative to the Cellectis SA Peer Group. Recent market returns have significantly outperformed the Cellectis SA Peer Group. Total shareholder returns expected to significantly lag the overall equity market. Based on current investor expectations, Cellectis SA shares should reach a level of $2 by 2028 — an -7.1% per year total shareholder return. A 2028 stock price of $5 would reflect median performance and a price of $6 would be required to reach upper quartile performance.
- Cellectis SA’s past growth is slightly below average. Historical growth has been below average relative to the Cellectis SA Peer Group and forecasted growth is relatively average. EPS Growth, Asset Growth, and Equity Growth have lagged. These factors have negatively affected market perceptions of Cellectis SA. Cellectis SA’s historical income statement and balance sheet growth are not available.
- Asset Turnover, Pretax ROA, Pretax Margin, and Return on Equity are all group lagging. These factors have negatively affected market perceptions of Cellectis SA. The company has normal cash needs.
- Cellectis SA’s risk profile is unfavorable. Overall variability has been very high with very high revenue variability, and very high stock price volatility. Financial Strength is below average and earnings’ expectations are only average. The debt/capital ratio has risen.
Be the first to comment